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Polychlorinated  biphenyls  (PCBs),  industrial  chemicals  and  persistent  environmental  pollutants,  are
found  in  rural  and urban  settings.  Rodent  studies  have  shown  that  exposure  to PCB126,  a  dioxin-like
PCB,  causes  a signiﬁcant  disruption  of  hepatic  micronutrient  homeostasis  and  an  increase  in metalloth-
ionein  (MT),  an  antioxidant  protein  and  metal  carrier.  A MT  knockout  mouse  strain  was used  to assess
metallothionein’s  role  in  micronutrient  disruption  and  overall  hepatotoxicity.  Twenty  four  129S  male
mice (12  wild  type  (WT)  and  12  MT knockout  (MTKO))  were  placed  on a puriﬁed  diet  (AIN-93G)  for  3
weeks  to  achieve  hepatic  metal  equilibrium.  Mice  were  then  given  a single  IP  injection  of  either  vehicle
or  150  mol/kg  PCB126  in vehicle.  The  animals  were sacriﬁced  2 weeks  later  and  organs  processed  for
analysis.  Liver  histology,  hepatic  lipids, gene  expression,  micronutrient  and  ROS  status  were investigated.
Liver  weights,  liver  lipids,  ROS,  and  hepatocyte  vacuolation  were  increased  with  PCB126  exposure  along
with AhR  responsive  genes.  The  MTKO  animals  had  more  severe  histological  changes  in the  liver andCB
hR
epatotoxicity
elevated  liver  lipids  than their  wild  type  counterparts.  Hepatic  and renal  metals  levels  (Cu,  Zn,  Se and
Mn)  were  mostly  reduced  by PCB126  treatment.  Renal  micronutrients  were  more  affected  by PCB126
treatment  in  the  MTKO  animals.  This  research  suggests  that  MT  may  not  be  the  sole/primary  cause  of
the  metal  disruption  caused  by  PCB126  exposure  in  mice,  but may  provide  protection  against  overall
hepatotoxicity.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Polychlorinated biphenyls (PCBs) are persistent environmental
nd industrial chemicals that continue to pose a threat to human
ealth because of their toxicity and recurrent exposure [2]. The
ecent elevation by IARC of these chemicals to group I carcinogens
xempliﬁes this threat [17]. Of the 209 congeners, the dioxin-
ike PCBs, in particular PCB126 (3,3′,4,4′,5-pentachlorobiphenyl),
ffect multiple targets through activation of the aryl-hydrocarbon
eceptor (AhR) [1]. This activation drives the induction of a multi-
licity of genes including xenobiotic metabolizing enzymes (e.g.,
ytochrome P450s (CYPs)) as well as antioxidant proteins, like
araoxonases and metallothionein [15,33]. In addition, studies
ave shown that PCB126 can alter the micronutrient status of
∗ Corresponding author at: Department of Occupational and Environmental
ealth, The University of Iowa, College of Public Health, 100 Oakdale Campus #219
REH, Iowa City, IW 52242-5000, United States. Fax: +1 319 335 4290.
E-mail address: larry-robertson@uiowa.edu (L.W. Robertson).
ttp://dx.doi.org/10.1016/j.toxrep.2015.12.001
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
the liver causing hepatic copper to increase whereas hepatic zinc,
selenium and manganese decrease [13]. The extent to which
micronutirent alterations exacerbate the ongoing liver damage is
not fully understood as is the mechanism by which these micronu-
trients are being altered.
Metallothionein is an important protein family that has several
roles alongside metal transport and reactive oxygen scavenging
[31]. The metallothionein family consists of 4 isoforms in mam-
mals. Two  main metallothioneins are ubiquitously expressed, MTI
and MTII, with especially high levels seen in the liver and kidney
[38]. They consist of a 6 kDa cytosolic protein with a large percent-
age of cysteine residues (≈30%) which mainly chelates intracellular
copper and zinc, but can also bind other metals [28]. The high thiol
content results in its antioxidant property and allows it to interact
with several metal ions at a time, in particular 7 zinc atoms or 12
copper atoms [4,28]. Given the molar equivalence, a small change
in its expression can result in a very marked change in the levels of
the metals bound to metallothionein. Metallothionein expression is
altered by many different inducers, including cytokines, hormones,
speciﬁcally glucocorticoids, and some metals [19,26]. Sato and
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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o-workers have shown that activation of the AhR induced changes
n metallothionein expression through interaction with the gluco-
orticoid receptor which corroborates work showing PCB126 can
lter metallothionein expression [12,32]. Aside from metal binding,
etallothionein has been shown to mitigate the toxicity of some
hemicals, including carbon tetrachloride and cadmium, and is
elieved to facilitate zinc’s abrogative properties in alcohol induced
iver damage [7,11,39]. Overall, metallothionein is a versatile pro-
ein that positively contributes to different aspects of cellular and
rgan health and whose properties may  be involved in the dynam-
cs of PCB126 mediated liver damage.
The liver injury characteristic of PCB126 exposure is believed,
n part, to be the result of reactive oxygen species (ROS) gener-
ted by idle CYPs, among other mechanisms [36]. Given the ROS
cavenging aspects of metallothionein and its metal binding ability,
etallothionein could be central to the hepatic toxicity of PCB126
n the context of micronutrient alterations and ROS. The hypothesis
f this study is that loss of metallothionein will result in increased
epatotoxicity with PCB126 exposure with alterations in micronu-
rient homeostasis. The role of metallothionein in micronutrient
lteration and hepatic injury caused by PCB126 is addressed using
 metallothionein knockout mouse line.
. Materials and methods
.1. Chemicals
Unless stated otherwise, all chemicals were obtained from
igma–Aldrich Chemical Company (St. Louis, MO). The synthe-
is of PCB126 followed the Suzuki coupling of 3,4-dichlorophenyl
oronic acid and 3,4,5-trichlorobenzene using a palladium cat-
lyzed cross coupling reaction [24]. The product was puriﬁed using
n aluminum oxide column with ﬂash silica gel column chro-
atography, ﬁnally being recrystallized with methanol. GC/MS
etermined the ﬁnal product purity to be >99.8% and 13C NMR  was
sed for conﬁrmation of structure. Caution: PCBs and their metabo-
ites should be handled as hazardous compounds in accordance
ith NIH guidelines.
.2. Animals
All animal procedures and experimental designs were per-
ormed with the approval of the Institutional Animal Care and
se Committee of the University of Iowa. Twelve male wild type
129S1/SvlmJ] mice (WT) and twelve male double knockout (MTI
nd MTII) MT−/− mice [129S7/SvEvBrd-Mt1-Mt2] (MTKO), 8–10
eeks of age, were purchased from Jackson Laboratories (Sacra-
ento, CA). The mice were housed three per cage and assigned
 treatment to effectively age match the different groups. The
ge of the mice was chosen given recent evidence of adolescent
CB exposure and the sensitivity/induction potential of that age
f animal [9,10]. Access was provided to water and a pelletized
IN-93G diet (Harlan Teklad; Madison, WI)  ad libitum throughout
he study. The animals were acclimatized for three weeks to reach
epatic micronutrient equilibrium [29]. Mice were then given a
ingle i.p. injection (5 ml/kg) of either vehicle (tocopherol stripped
oy oil) or a dose of 150 mol/kg PCB126 in vehicle. This dose
nd route of administration was chosen based on previous stud-
es with similar AhR nonresponsive mouse strains that showed
omparable hepatic effects to earlier rat studies [30]. The result-
ng four groups of six animals each (WT—vehicle; WT—PCB126;
TKO—vehicle; MTKO—PCB126) were monitored for two weeks
ollowing the injections, then mice were euthanized with carbon
ioxide followed by cervical dislocation; blood, liver and other
rgans were removed and processed for further analysis. The geno-Reports 3 (2016) 21–28
type of the animals was  conﬁrmed from a small piece of liver with
the help of Transnetyx (Cordova, TN).
2.3. Histology
A small piece of liver was  ﬁxed in 10% neutral buffered forma-
lin. Formalin ﬁxed tissue was  routinely processed and embedded
in parafﬁn followed by sectioning at 4 m.  Sections were then
stained with hematoxylin and eosin (H&E) and examined by a
board-certiﬁed veterinary pathologist (KN G-C).
2.4. Micronutrient analysis
0.5 g of liver and kidney were weighed and placed into acid
washed 15 ml  polyethylene tubes. Acid digestion was conducted
with a 4:1 ratio of nitric acid and 30% hydrogen peroxide fol-
lowed by heat block treatment at >110 ◦C for 2 h. Once the samples
were thoroughly digested, a Thermo X-series II inductively coupled
plasma–mass spectrometer (ICP-MS) with collision cell and Cetac
autosampler was  used to determine micronutrient status. Analysis
was performed at the Iowa Trace Element Analysis Laboratory at
the University of Iowa with the assistance of Dr. David Peate.
2.5. Lipid extraction
0.25–0.75 g pieces of liver were homogenized with diatoma-
ceous earth with a mortar and pestle and extracted using
Accelerated Solvent Extraction (Dionex, Sunnyvale, CA), as
described previously, utilizing chloroform:methanol (2:1 v/v) [5].
Extracted samples were initially concentrated and placed in pre-
weighed vials followed by evaporating and heating to dryness.
Dried samples were placed in a desiccator and weighed several
times until constant weight was  achieved, usually taking several
days. Weights were expressed relative to weight of the liver piece
used.
2.6. Gene expression
The gene expression of several proteins was assessed using a
two-step RT-PCR method utilizing an Eppendorf Realplex Master-
cycler. First mRNA was isolated from a small piece of liver using
a Qiagen (Hilden, Germany) RNeasy Mini kit, as per the manu-
facturer’s instructions. Total mRNA concentration and purity was
conﬁrmed by measuring absorbance at 260 nm and 280 nm. A High
Capacity cDNA Reverse Transcription Kit from Applied Biosystems
(Waltham, MA)  was  used to reverse transcribe the mRNA to cDNA.
10 ng cDNA was  used along with 300 nM primers and a SYBR green
PCR master mix  (Applied Biosystem) for the real time RT-PCR. The
reaction conditions for all primer sets were optimized and two
technical replicates were used. Primer sequences were obtained
from references and are given in Supplementary Table 1 [18,20]. All
primers were purchased from Integrated DNA Technologies (IDT)
(Coralville, IA). GAPDH was used as a reference gene and the wild
type vehicle group functioned as the biological control.
2.7. ROS determination
An OxiSelect InVitro ROS/RNS Assay Kit from Cell Biolabs (San
Diego, CA) was used to determine the level of ROS in the liver.
Brieﬂy, liver samples were homogenized with PBS and diluted to a
uniform concentration. Samples were added to both catalyst and a
ﬂuorescein based dye in a 96 well plate. The plate was incubated
at room temperature for 45 min. The ﬂuorescence of the dichlo-
roﬂuorescein dye (DCF) was determined at 480 nm excitation and
530 nm emission. Samples were analyzed in triplicate. A DCF stan-
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Fig. 1. Increased hepatotoxicity seen with PCB126 in MTKO animals.
WT  and MTKO animals were treated once, intraperitoneally, with 150 mol/kg PCB126. After 2 weeks the animals were sacriﬁced. Liver sections were stained with hematoxylin
and  eosin and analyzed by a pathologist. (A) WT animal treated with vehicle. (B) WT animal treated with PCB126. (C) MTKO animal treated with vehicle. (D) MTKO
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icrovesicular hepatocellular vacuolation and thick arrows indicate macrovesicular
egion.  These are representative images taken from each group. (Bars = 200 m;  Ins
ard curve was established to convert the raw ﬂuorescence and
nally the values were adjusted to tissue weight.
.8. COMET assay
The alkaline COMET assay was performed following the pro-
ocol by Speit et al. with slight modiﬁcations to detect a broad
pectrum of DNA lesions [35]. Whole blood was collected from the
eart and 10 L were mixed with 40 L low melting point (LMP)
garose (37 ◦C, 0.5% in PBS) and added onto a microscope slide cov-
red with 1.5% agarose. Slides were then transferred to 4 ◦C until
garose hardened and cold lysis buffer was added for 1 h. Slides
ere then placed in an alkaline buffer (pH > 13) to unwind the DNA
or 1 h. The slides were transferred to an electrophoresis apparatus
nd exposed to 24–25 V and 300 mA  for 30 min. After staining with
thidium bromide, images of cells were taken using an Axio A1
mager epiﬂuorescence microscope with a 40-fold objective, and
n Axio Cam MRm  camera (Zeiss, Jena, Germany). Images of 200
andomly selected cells were analyzed from each coded slide with
OMETScore pro (TriTek; Sumerduck, VA) and the% of DNA in the
ail was calculated as a measure for DNA migration.
.9. Statistics
To assess statistical signiﬁcance, a 2-way ANOVA was conducted
long with a Tukey’s multiple comparison test to conﬁrm differ-
nces between groups. Statistics were calculated in SAS 9.3 or
raphPad Prism 6 and signiﬁcance of p-value < 0.05 is notated by
n *.een genotypes and was exacerbated with PCB126 treatment. Thin arrows indicate
ocellular vacuolation. Hepatic injury was relegated to the centrilobular to midzonal
s = 50 m).
3. Results
3.1. Histological examination
A hallmark of exposure to dioxin-like compounds is pathology in
the liver of exposed animals. H&E liver sections were prepared for
the determination of hepatotoxicity of PCB126 and the contribution
of metallothionein expression. Within the vehicle control groups,
the MTKO had increased hepatocellular vacuolation, cytomegaly
and karyomegaly in the centrilobular to midzonal regions com-
pared to the wild type controls (Fig. 1A, C). Upon PCB126 treatment,
the wild type animals had marked microvesicular and scattered
macrovesicular hepatocellular vacuolation which was more pro-
nounced in the MTKO animals (Fig. 1B, D). This hepatic injury was
predominantly seen in the centrilobular to midzonal hepatocytes.
In addition, the MTKO PCB126 treated group exhibited the most
extensive inﬂammation of all the groups. This inﬂammation pre-
sented as mixed inﬂammatory cell inﬁltration by neutrophils, with
fewer macrophages, eosinophils, and lymphocytes. Overall, the
absence of metallothionein contributed to an increase in PCB126
liver injury.
3.2. AhR activation
Canonical metrics for AhR activation were investigated to con-
ﬁrm the traditionally seen pathologies associated with PCB126
exposure and the effects of metallothionein deﬁciency. Relative
liver weight was signiﬁcantly increased following PCB126 expo-
sure; genotype appeared to have no effect (Fig. 2). Absolute liver
weights were increased as well (data not shown). As a means of
quantifying the extent of liver damage, particularly hepatocellular
vacuolation, hepatic lipids were extracted and measured. In agree-
24 W.D  Klaren et al. / Toxicology Reports 3 (2016) 21–28
Fig. 2. Canonical AhR activation observed in both WT and MTKO mice with exposure to PCB126.
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 < 0.05; two-way ANOVA; n = 6).
ent with the vacuolation seen in the histology, hepatic lipids
ere increased with PCB126 exposure. A signiﬁcant difference
as also seen between the WT  and MTKO groups, both vehicle or
CB126 treated groups. This gives additional weight to the pro-
osed function of metallothionein in protecting the liver. The gene
xpression of two AhR responsive genes, CYP1A2 and UGT1A1,
as also investigated to conﬁrm AhR activation. CYP1A2, a fam-
ly 1 cytochrome P450 enzyme, was strongly induced with PCB126
reatment in both WT  and MTKO. However, PCB126 treated MTKO
ad a signiﬁcantly higher induction of CYP1A2 (Fig. 2). Uridine 5′-
iphospho-glucuronosyltransferases (UGT) are important enzymes
n phase II metabolism. UGT1A1, a known AhR target, was increased
n both WT  and MTKO with PCB126 exposure, however no differ-
nce was seen between genotypes (Fig. 2).
.3. Presence of ROS
PCB126 exposure is known to increase ROS. Several metrics
ere investigated to determine the presence of ROS and the effect
f metallothionein, a ROS scavenger. Hepatic ROS was  increased,
egardless of genotype, with PCB126 treatment (Fig. 3). ROS are
nown to induce DNA strand breaks. A genotoxic endpoint, the
OMET assay, was used to investigate the contribution of PCB126
xposure and/or metallothionein deﬁciency to systemic genotoxi-
ity. The amount of fragmented DNA in whole blood lymphocytes
as signiﬁcantly elevated after PCB126 exposure as seen in thencreased percentage of DNA in the COMET tails. No difference
as observed between the WT  and MTKO (Fig. 3). Transcriptional
ctivation of genes in a ROS sensitive pathway has been reported
nd therefore the gene expression of two genes, nuclear factorlipid accumulation by treatment of PCB126 and a more pronounced effect is seen in
administration with some effect of genotype. (Bars are standard error; *represents
(erythroid-derived 2)-like 2 (Nrf2) and NAD(P)H quinone oxidore-
ductase 1 (NQO1), involved in that pathway, was investigated. The
expression of both genes was elevated in the PCB126 groups, irre-
spective of genetic background (Fig. 3). In sum, these data suggest
an increase of ROS after PCB126 exposure with little effect of the
presence of metallothionein.
3.4. Micronutrient analysis
A major function of metallothionein is in regulating the
micronutrient homeostasis in tissues. Micronutrient status was
determined using ICP-MS to assess the role of metallothionein
in the normal physiological homeostasis of micronutrients and
PCB126 mediated modulation in the liver. A small decrease was
seen in hepatic copper with PCB126 treatment regardless of geno-
type but this decrease was  statistically signiﬁcant only in the MTKO
group (Fig. 4). Hepatic zinc was decreased in both the wild type and
MTKO animals following PCB126 exposure (Fig. 4). Although not
signiﬁcant, hepatic Se was  decreased with PCB126 exposure, sim-
ilar to zinc. Neither Cu, Zn, nor Se was  signiﬁcantly inﬂuenced by
the absence of metallothionein I and II in the liver. The only hepatic
metal that appears to be affected by the loss of metallothionein is
manganese which was seen to increase in the MTKO mice; however
PCB126 abrogated that increase (Fig. 4).
The kidneys are an organ with high MTI  and II expression. Renal
copper signiﬁcantly decreased in the MTKO PCB126 treated ani-
mals while all other groups were unaffected (Fig. 5). Renal zinc was
unaffected in the vehicle treated MTKO groups compared to the WT
controls. A decrease was  seen in the PCB126 treated MTKO animals
which was signiﬁcant compared to the corresponding WT  group
W.D  Klaren et al. / Toxicology Reports 3 (2016) 21–28 25
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epatic ROS was increased with PCB126 as was the fragmented DNA in whole blo
esponsive genes were induced with PCB126 exposure but no difference observed b
nd compared to the MTKO vehicle control group (Fig. 5). Although
ot signiﬁcant, a similar pattern was seen with renal selenium,
 difference because of PCB126 treatment and MTKO genotype.
lso, renal manganese was only affected in the MTKO group where
CB126 treatment signiﬁcantly decreased the Mn  levels. Thus a sig-
iﬁcant consistent decrease was seen with renal Cu, Zn, Mn  and Se
not signiﬁcant) in the MTKO animals following PCB126 exposure.
. Discussion
Metallothionein has been shown to be protective against many
ifference toxic agents including acetaminophen, cadmium, cis-
latin, and carbon tetrachloride [7,11,22,23,25]. Given its role in
oth metal transport and oxidant scavenging, it seems a prime
andidate for potentially mediating a well observed phenomenon
ssociated with PCB126, the disruption of micronutrient homeo-
tasis in rodent liver. Early studies have shown that animals
reated with PCB126 have disrupted hepatic micronutrients yet
 clear explanation of how this is occurring and how this con-
ributes to the broader hepatotoxicity are unknown [15]. This
tudy sets out to address the involvement of metallothionein in
CB126-mediated hepatic micronutrient disruption and its poten-
ial protective capacity.
In micronutrient investigations, it is important to consider the
hanges that occur with body weight to ensure that the effect
s due to the toxic agent itself and not from dietary or wasting
echanisms. Body weight was monitored over the course of the
tudy and was uniform before and after PCB126 treatment (Sup-
lementary Fig. 1). Interestingly, the MTKO animals had a marginal
ncrease in body weight however this was not signiﬁcant andtween WT and MTKO mice.
phocytes as measured by the COMET assay in both WT and MTKO animals. ROS
n genotypes. (Bars are standard error; * represents p < 0.05; two-way ANOVA; n = 6)
has been observed before [3]. Elsenshans et al. established the
hypophagia/cachexia independent effects of TCDD, a PCB126-like
compound, by using a pairwise feeding model with rats which
conﬁrms that the effects on micronutrients seen are unlikely
hypophagia/cachexia mediated [8].
The histology analysis showed a marked difference between
the WT and the MTKO animals, even in the vehicle treated ani-
mals, suggesting that the loss of metallothionein alone alters the
liver (Fig. 1). Interestingly, in many studies with similar mouse
strains (MTI/II knockouts), this alteration in liver histology was not
observed [7,22,23]. However, Beattie et al. have described a natu-
ral partitioning of MT-null mice by body weight into distinct lean,
average, and obese groups [3]. Of the MTKO mice, the obese MTKO
group had a higher hepatic lipid content and liver weight, compared
to controls. Unfortunately this research group did not investigate
the liver histologically. The MTKO animals in the present study were
slightly heavier than the WT  controls and displayed increased hep-
atic lipids (Supplementary Fig. 1; Fig. 2). This increased weight may
have played a role in the difference in liver histology and lipids
observed between the genotypes. However, there was also a clear
increase in liver injury with PCB126 treatment which was more
pronounced in the MTKO mice, not only with respect to vacuolation,
which was conﬁrmed with the increase in hepatic lipids (Fig. 2), but
also in the form of increased inﬂammation.
PCB126 produced classical AhR activation effects. Relative liver
weight, CYP1A2 and UGT1A1 expression were increased with
PCB126 in WT  and MTKO animals (Fig. 2). Interestingly, CYP1A2
was signiﬁcantly increased in the MTKO animals compared to its
PCB126 treated WT  control. This has not been observed before
in vivo but work in cell culture has shown that low levels of cop-
26 W.D  Klaren et al. / Toxicology Reports 3 (2016) 21–28
Fig. 4. Hepatic micronutrients are altered following PCB126 exposure with only Mn showing a genotypic effect.
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pepatic Cu is decreased with PCB126, a rather novel ﬁnding that differs from prev
hat  alterations in zinc are metallothionein independent. Hepatic Se is unchanged w
ncreased between WT  and MTKO mice in the liver. (Bars are standard error; * repr
er resulted in increased expression of CYP1A2 [6]. In addition,
he MTKO group treated with PCB126 had signiﬁcantly lower hep-
tic Cu levels and indeed were the lowest Cu levels of all 4 groups
Fig. 4), which may  suggest a combined effect of PCB126 and met-
llothionein on CYP expression.
Reactive oxygen species are commonly observed following
CB126 exposure or AhR activation [36]. Hepatic ROS and ROS
esponsive genes were all increased with PCB126 treatment as
ere DNA strand breaks (COMET assay) however genotype had lit-
le effect (Fig. 3). It is believed that the protective properties of
etallothionein against other toxicants is through the increased
vailability of zinc and not solely by ROS scavenging itself, partic-
larly in cases of carbon tetrachloride and alcohol induced liver
amage [7]. Altered zinc status was not observed in untreated
TKO animals (Fig. 3) so the compensatory storage mechanism by
hich zinc levels are maintained is more rigid than the metalloth-
onein system. This rigidity hinders the availability of zinc needed
or abrogating liver injury. Additional studies looking into any com-
ensatory storage system as a result of metallothionein loss and to
inc homeostasis in general are needed.
Our lab has shown previously the effect of PCB126 on hepatic
icronutrients in rats [13,14,16]. Similar trends were observed
n this study using mice with the notable exception of copper
Fig. 4). In the rat, hepatic copper increases with PCB126 treat-
ent which was therefore initially hypothesized to be a response
o increased metallothionein [15]. In this study, hepatic copper is
asically unchanged in WT  animals and signiﬁcantly decreased in
TKO animals following exposure to PCB126. Decreased hepatic
opper has been observed before in MTKO animals, when com-
ared to control animals, but was seen much later, around 29–33tudies in rats. Hepatic Zn is decreased in both WT and MTKO animals suggesting
xposure however slight decreases are observed. Mn is unaffected by PCB126 but is
 p < 0.05; two-way ANOVA; n = 6)
weeks of age [3]. It is noteworthy that differential gene expression
has been observed between rats and mice following TCDD exposure
[27]. In particular, transcription factors, i.e., the Sp family, are mod-
ulated differently. These transcription factors have been shown to
be important for copper homeostasis [34,37]. Additional research is
warranted to further dissect the interspecies differences observed.
Other micronutrients in the liver, Zn, Se, and Mn, were observed to
change as previously seen (Fig. 4) [13]. In particular, Zn and Se were
decreased with PCB126 exposure suggesting alterations in zinc and
selenium status appear to be metallothionein independent in the
mouse. Interestingly, Mn  increased in MTKO animals and is rela-
tively unchanged with PCB126 treatment. MTKO animals have been
shown to alter the expression of superoxide dismutase enzymes,
decreasing Cu/ZnSOD and slightly increasing MnSOD, which may
be contributing, in part, to the increases seen here [21]. The increase
in hepatic Mn  and the effect of metallothionein loss on SODs may
indicate elevated antioxidant proteins to counterbalance the loss
of metallothionein; this is corroborated with the activation of the
Nrf2 pathway.
Renal micronutrients remained stable in the WT  group after
PCB126 treatment. This is different from what has been seen
previously in rats, where increases in copper, selenium, and man-
ganese were observed (Fig. 5) [15]. This is possibly explained by
interspecies differences that have been discussed previously [27].
Interestingly, PCB126 appears to have an effect in the MTKO ani-
mals in the context of renal micronutrients. Cu, Zn, and Mn were
all signiﬁcantly decreased as well as Se, although not signiﬁcantly.
These changes are unlikely due to altered excretion, since copper,
zinc, and manganese are traditionally excreted via bile, not in the
urine. Previous studies in wild type animals show minor effects in
W.D  Klaren et al. / Toxicology Reports 3 (2016) 21–28 27
Fig. 5. MTKO mice are susceptible to renal micronutrient disruption caused by PCB126.
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Appendix A. Supplementary dataenal copper, zinc, and manganese are all decreased in the MTKO animals following 
reatment. (Bars are standard error; * represents p < 0.05; two-way ANOVA; n = 6).
he kidney following PCB126 exposure [13]. This rather novel ﬁnd-
ng suggests a speciﬁc renal sensitivity to PCB126 toxicity caused
y a lack of metallothionein. The mechanism for this sensitivity is
nknown and could be the result of a compensatory system which
aintains levels but is unable to respond to a stress response. Stud-
es are warranted to investigate the metallothionein-independent
echanisms of micronutrient homeostasis as is suggested above in
he context of zinc.
Given that the only signiﬁcant differences seen between vehi-
le treated WT  and MTKO animals were hepatic lipid content and
epatic Mn,  the increased toxicity that is seen with PCB126 in
TKO compared to WT  mice with respect to histological ﬁnd-
ngs and renal metal content could be additive to the underlying
eﬁcits that lacking metallothionein causes. The true protec-
ive potential of metallothionein against PCB126 needs further
nvestigation using an overexpression model. Potential use of a
inc supplementation model would ensure sufﬁcient and labile
ools of zinc which has shown to be important for mitigation
f other hepatotoxicants. In addition, the difference seen his-
ologically, particularly with respect to hepatocyte vacuolation,
nd the lack of difference seen in ROS metrics, suggests that
CB126 hepatotoxicity is not exclusively ROS mediated. This is
n important consideration for future studies investigating poten-
ial therapeutic interventions. The mechanisms by which the
ombination of metallothionein deﬁciency makes the liver more
usceptible to damage by PCB126 needs further studies. How-
ver it is clear that metallothionein plays a minor role in the
isruption of hepatic and renal micronutrient status caused by
CB126.6 administration. Renal Se is unaffected by both loss of metallothionein and PCB126
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